Development of fish tests for endocrine disruptors

被引:29
|
作者
Hutchinson, TH [1 ]
Yokota, H
Hagino, S
Ozato, K
机构
[1] AstraZeneca Global Safety Hlth & Environm, Brixham Environm Lab, Brixham TQ5 8BA, Devon, England
[2] Sumika Technoserv Corp, Takarazuka, Hyogo, Japan
[3] Nagoya Univ, Biosci Ctr, Nagoya, Aichi, Japan
关键词
D O I
10.1351/pac200375112343
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
International concern over endocrine active substances (EASs) has led to intensive research programs to establish fish reproductive and developmental toxicity tests for use in environmental (ecological) risk assessment. This chapter gives an overview of key themes of in vivo ecotoxicology research, including fish screening assays, partial life-cycle tests (the draft Organization for Economic Cooperation and Development (OECD) fish reproduction test and the new fish development test) and fish full life-cycle tests. In the context of the OECD test guidelines program, fish species of primary interest include fathead minnow, medaka, and zebrafish, while guppy, rainbow trout, sheepshead minnow, and three-spined stickleback are also of scientific importance. Critical factors for evaluation include baseline reproductive biology and definition of EAS sensitive life-stages. For regulatory applications, a critical review of existing fish EAS data suggests that apical adverse effect endpoints, namely development, growth and reproduction (e.g., fecundity, fertilization rates and hatching success) should be used to derive predicted no effect concentrations (PNECs) for the environmental risk assessment of EASs. In support of these apical adverse effect endpoints, biomarker responses (e.g., vitellogenin, gonadal-somatic index, and gonad histopathology) should be used to provide mechanistic data, compare species (e.g., cyprinids vs. salmonids) and allow extrapolation between laboratory and field studies.
引用
收藏
页码:2343 / 2353
页数:11
相关论文
共 50 条
  • [31] Biomarkers for endocrine disruptors in three species of Mediterranean large pelagic fish
    Fossi, MC
    Casini, S
    Marsili, L
    Neri, G
    Mori, G
    Ancora, S
    Moscatelli, A
    Ausili, A
    Notarbartolo-di-Sciara, G
    MARINE ENVIRONMENTAL RESEARCH, 2002, 54 (3-5) : 667 - 671
  • [32] Endocrine disruptors in female reproductive tract development and carcinogenesis
    Ma, Liang
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2009, 20 (07): : 357 - 363
  • [33] Effects of endocrine disruptors in the development of the female reproductive tract
    Frade Costa, Elaine Maria
    Spritzer, Poli Mara
    Hohl, Alexandre
    Bachega, Tania A. S. S.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2014, 58 (02) : 153 - 161
  • [34] Action of endocrine disruptors in urogenital development in chicken embryo
    Biau, S.
    Roig, B.
    De Santa Barbara, P.
    EPIDEMIOLOGY, 2006, 17 (06) : S335 - S335
  • [35] Endocrine disruptors also function as nervous disruptors and can be renamed endocrine and nervous disruptors (ENDs)
    Seralini, Gilles-Eric
    Jungers, Gerald
    TOXICOLOGY REPORTS, 2021, 8 : 1538 - 1557
  • [36] Neoplasia as development gone awry: the role of endocrine disruptors
    Soto, Ana M.
    Maffini, Maricel V.
    Sonnenschein, Carlos
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2008, 31 (02): : 288 - 292
  • [37] The Impact of Endocrine Disruptors on Endocrine Targets
    Gregoraszczuk, Ewa L.
    Kovacevic, Radmila
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
  • [38] The Impact of Endocrine Disruptors on Endocrine Targets
    Diamanti-Kandarakis, E.
    Palioura, E.
    Kandarakis, S. A.
    Koutsilieris, M.
    HORMONE AND METABOLIC RESEARCH, 2010, 42 (08) : 543 - 552
  • [39] Endocrine disruptors - CIA cannot help with disruptors
    不详
    EUROPEAN CHEMICAL NEWS, 1998, 69 (1813): : 24 - 24
  • [40] Endocrine Disruptors and Puberty
    Laron, Zvi
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2013, 10 (03) : 337 - 337